Pages that link to "Q1152227"
Jump to navigation
Jump to search
The following pages link to pharmacogenomics (Q1152227):
Displaying 50 items.
- DNAPrint Genomics (Q5205713) (← links)
- The Pharmacogenomics Journal (Q10534704) (← links)
- (Q12606165) (redirect page) (← links)
- Pharmacogenomics (Q15724625) (← links)
- Translating pharmacogenomics: challenges on the road to the clinic (Q21092371) (← links)
- KRAS mutational analysis for colorectal cancerApplication: Pharmacogenomic (Q21128654) (← links)
- Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine (Q21132550) (← links)
- Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients (Q21144330) (← links)
- Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs (Q21284753) (← links)
- Chapter 7: Pharmacogenomics (Q21563496) (← links)
- Pharmacogenetics, Pharmacogenomics, and Individualized Medicine (Q23919667) (← links)
- Cancer pharmacogenomics: strategies and challenges (Q24289309) (← links)
- Pharmacogenetics, pharmacogenomics and ecogenetics (Q24537990) (← links)
- Pharmacogenetics and pharmacogenomics (Q24564983) (← links)
- Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process (Q24567778) (← links)
- Pharmacogenomics knowledge for personalized medicine (Q24623166) (← links)
- Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs (Q24630309) (← links)
- From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource (Q24632079) (← links)
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network (Q24632735) (← links)
- Genetics of migraine and pharmacogenomics: some considerations (Q24654656) (← links)
- Clinical use of pharmacogenomic tests in 2009 (Q24657536) (← links)
- Pharmacogenetics, pharmacogenomics and airway disease (Q24798917) (← links)
- Pharmacogenomics arrives (Q24804608) (← links)
- FDA eyes pharmacogenomics data (Q24813169) (← links)
- The reality of pharmacogenomics: optimizing therapeutic decision making (Q24815907) (← links)
- Pharmacogenomics: the promise of personalized medicine (Q24815931) (← links)
- Adding pharmacogenomics to the development of new marine-derived anticancer agents (Q25254985) (← links)
- Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives (Q26741009) (← links)
- Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease (Q26748481) (← links)
- Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art (Q26750720) (← links)
- The pharmacogenomics of pain management: prospects for personalized medicine (Q26765266) (← links)
- Pharmacogenomics for personalized pain medicine (Q26765791) (← links)
- Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response (Q26772028) (← links)
- Rational selection of predictive pharmacogenomics test for the Fluoropyrimidine/Oxaliplatin based therapy (Q26774358) (← links)
- Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility (Q26775813) (← links)
- microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment (Q26778918) (← links)
- Pharmacogenomics in the clinic (Q26782786) (← links)
- The epigenome, 4D nucleome and next-generation neuropsychiatric pharmacogenomics (Q26785674) (← links)
- Cardiovascular pharmacogenomics: current status and future directions (Q26801183) (← links)
- Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics (Q26801410) (← links)
- Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics (Q26822796) (← links)
- The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics (Q26825275) (← links)
- A conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomics (Q26827814) (← links)
- Genetics of resistant hypertension: a novel pharmacogenomics phenotype (Q26851506) (← links)
- Perspectives on pharmacogenomics of antiretroviral medications and HIV-associated comorbidities (Q26853274) (← links)
- Integrative systems biology approaches in asthma pharmacogenomics (Q26861541) (← links)
- Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer (Q26863490) (← links)
- Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease (Q26865524) (← links)
- Pharmacogenomics and cardiovascular disease (Q26997380) (← links)
- Pharmacogenomics of human P450 oxidoreductase (Q26998463) (← links)